Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 100.84
(-0.89%)
CNY 100.84
(-0.89%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.06 Billion CNY | 36.42% |
| 2022 | 2.24 Billion CNY | 9.61% |
| 2021 | 2.04 Billion CNY | 24.97% |
| 2020 | 1.63 Billion CNY | 138.93% |
| 2019 | 685.78 Million CNY | 16.94% |
| 2018 | 586.45 Million CNY | 112.43% |
| 2017 | 276.06 Million CNY | 18.28% |
| 2016 | 233.39 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.42 Billion CNY | 12.93% |
| 2024 Q1 | 3.03 Billion CNY | -0.87% |
| 2023 Q4 | 3.06 Billion CNY | 22.39% |
| 2023 FY | 3.06 Billion CNY | 36.42% |
| 2023 Q2 | 2.35 Billion CNY | 1.65% |
| 2023 Q1 | 2.32 Billion CNY | 3.39% |
| 2023 Q3 | 2.5 Billion CNY | 6.06% |
| 2022 Q3 | 2.23 Billion CNY | 2.8% |
| 2022 Q1 | 2.09 Billion CNY | 2.13% |
| 2022 FY | 2.24 Billion CNY | 9.61% |
| 2022 Q4 | 2.24 Billion CNY | 0.4% |
| 2022 Q2 | 2.17 Billion CNY | 3.99% |
| 2021 Q2 | 1.76 Billion CNY | 6.65% |
| 2021 FY | 2.04 Billion CNY | 24.97% |
| 2021 Q1 | 1.65 Billion CNY | 0.98% |
| 2021 Q4 | 2.04 Billion CNY | 7.39% |
| 2021 Q3 | 1.9 Billion CNY | 8.06% |
| 2020 FY | 1.63 Billion CNY | 138.93% |
| 2020 Q4 | 1.63 Billion CNY | 4.74% |
| 2020 Q3 | 1.56 Billion CNY | 115.85% |
| 2020 Q2 | 724.72 Million CNY | 6.62% |
| 2020 Q1 | 679.76 Million CNY | -0.88% |
| 2019 FY | 685.78 Million CNY | 16.94% |
| 2019 Q2 | 662.54 Million CNY | 0.0% |
| 2019 Q3 | 668.93 Million CNY | 0.96% |
| 2019 Q4 | 685.78 Million CNY | 2.52% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 586.45 Million CNY | 112.43% |
| 2018 Q4 | 586.45 Million CNY | 0.0% |
| 2017 FY | 276.06 Million CNY | 18.28% |
| 2016 FY | 233.39 Million CNY | 0.0% |